REGULATED CRYPTO EXCHANGE
Русский
Español
Arcturus Therapeutics Holdings Inc.
Sell13.90
Spread0.23
Buy14.13

Trade Arcturus Therapeutics Holdings Inc. - ARCT stock price

Sell13.90
Spread0.23
Buy14.13
1m
5m
15m
30m
1H
4H
1D
1W
History
Open on platform
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the treatment of liver and respiratory care diseases. The company engages in the discovery and development of RNA medicines, including the production of RNA drug substance and nanoparticle-formulated drug product; and development of infectious disease vaccines using its Self-Transcribing and Replicating RNA (STARR) technology. Its preclinical drug discovery and development programs include LUNAR-OTC development program that is developing mRNA compounds to treat ornithine transcarbamylase (OTC) deficiency; LUNAR-CF program, which is developing mRNA compounds to replace dysfunctional cystic fibrosis transmembrane conductance regulator (CFTR) protein in cystic fibrosis (CF) patients; and LUNAR-CV and LUNAR-MD that are internal research programs focused on target validation of multiple pipeline LUNAR-mRNA program candidates. The company owns LUNAR and nucleic acid technologies that are covered by a patent portfolio of 182 patents and patent applications, issued in the United States, China, Europe, Japan, and other countries. It has collaboration partnerships with Ultragenyx Pharmaceutical, Inc. to develop mRNA therapeutic candidates for certain rare disease targets; Millennium Pharmaceuticals, Inc. (Takeda) to develop a nucleic acid-based therapeutic candidate for the treatment of nonalcoholic steatohepatitis; Janssen Pharmaceuticals, Inc. to develop nucleic acid-based therapeutic candidates for the treatment of hepatitis B virus infection; CureVac AG; Singapore Economic Development Board and Duke-NUS Medical School to develop LUNAR-COV19, a vaccine to address the Coronavirus outbreak; and Catalent, Inc. to support the expected manufacture of Arcturus'' COVID-19 mRNA vaccine candidate (LUNAR-COV19. Arcturus Therapeutics Holdings Inc. was founded in 2013 and is headquartered in San Diego, California.
White Paper Declaration

Trade the world’s top tokenised stocks, indices, commodities and currencies with the help of crypto or fiat

Download on the App Store Get it on Google Play Explore platform Show QR
Articles
US government transfers $922m in Bitcoin from seized Bitfinex hack funds
Read more
Bitcoin whales invest $700b as BTC price heads to $70k
Read more
Bitcoin hits $60k for first time since November 2021
Read more
Jeeves eyes Middle East launch by 2025, CEO hints at Web Summit Qatar 2024
Read more
1 BTC
Invest
50 BTC
Profit
Leverage:
x50

The Power Of Leverage

Trade in the big leagues with 100 Bitcoin for every 1 Bitcoin you put in

ARCT price history

  • Last 7 days
  • Last 30 days
  • Last Year
  • Last 2 Years
  • Maximum Period
  • Daily
  • Weekly
  • Monthly
Date Close Change Chg% Open Min. Max.
2022-09-30 13.9 -0.49 -3.41 14.39 13.84 14.48
2022-09-30 15.03 1.21 8.76 13.82 13.77 15.21
2022-09-30 14.1 1.11 8.55 12.99 12.99 14.19
2022-09-30 12.98 -0.39 -2.92 13.37 12.97 14.46
2022-09-30 13.59 0.24 1.80 13.35 13.03 14.11
2022-09-30 13.92 -0.23 -1.63 14.15 13.53 14.25
2022-09-30 14.37 -0.55 -3.69 14.92 14.28 15.33
2022-09-30 14.92 0.20 1.36 14.72 14.53 15.5
2022-09-30 15.26 0.13 0.86 15.13 14.21 15.45
2022-09-30 15.48 -0.14 -0.90 15.62 14.65 15.78
2022-09-30 16.29 0.58 3.69 15.71 15.16 16.62
2022-09-30 15.79 0.49 3.20 15.3 15.03 16.23
2022-09-30 15.59 0.23 1.50 15.36 15.22 16.11
2022-09-30 16.38 0.95 6.16 15.43 15.26 16.44
2022-09-30 15.38 0.29 1.92 15.09 14.69 15.66
2022-09-30 15.07 0.72 5.02 14.35 14.18 15.32
2022-09-30 14.61 1.08 7.98 13.53 13.46 14.71
2022-09-30 13.72 -0.55 -3.85 14.27 13.61 14.3
2022-09-30 14.29 -1.00 -6.54 15.29 14.03 15.42
2022-09-30 15.42 1.15 8.06 14.27 13.51 15.43
Go help.dzengi.com